HHS Public Access Author manuscript Author Manuscript
Int J Cancer. Author manuscript; available in PMC 2017 January 09. Published in final edited form as: Int J Cancer. 2016 November 01; 139(9): 2146. doi:10.1002/ijc.30271.
Retraction This article has been retracted at the request of: Editor-in-Chief and Co-author ‘Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo’ by Banerjee, S., Kong, D., Azmi, A. S., Wang, Z., Ahmad, A., Sethi, S. and Sarkar, F. H.
Author Manuscript
The above article, published online on 16 November 2010, in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor-in-Chief, Professor Peter Lichter, and Wiley Periodicals, Inc. A university investigation involving the first and corresponding author determined that several figures in this paper were mislabeled, manipulated, or duplicated and relabeled while processing/ compiling the final figures assembled from the original data sources. Therefore, the authors are retracting the paper in its entirety although they maintain that these issues did not affect the major conclusions. They apologize for any inconvenience this may have caused. Reference
Author Manuscript
Banerjee, S., Kong, D., Azmi, A. S., Wang, Z., Ahmad, A., Sethi, S. and Sarkar, F. H. (2011), Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo. Int. J. Cancer, 128: 1240–1250. doi: 10.1002/ijc. 25658 DOI: 10.1002/ijc.30271
Author Manuscript
Int J Cancer. Author manuscript; available in PMC 2017 January 09. Published in final edited form as: Int J Cancer. 2016 November 01; 139(9): 2146. doi:10.1002/ijc.30271.
Retraction This article has been retracted at the request of: Editor-in-Chief and Co-author ‘Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo’ by Banerjee, S., Kong, D., Azmi, A. S., Wang, Z., Ahmad, A., Sethi, S. and Sarkar, F. H.
Author Manuscript
The above article, published online on 16 November 2010, in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor-in-Chief, Professor Peter Lichter, and Wiley Periodicals, Inc. A university investigation involving the first and corresponding author determined that several figures in this paper were mislabeled, manipulated, or duplicated and relabeled while processing/ compiling the final figures assembled from the original data sources. Therefore, the authors are retracting the paper in its entirety although they maintain that these issues did not affect the major conclusions. They apologize for any inconvenience this may have caused. Reference
Author Manuscript
Banerjee, S., Kong, D., Azmi, A. S., Wang, Z., Ahmad, A., Sethi, S. and Sarkar, F. H. (2011), Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cells in vitro and in vivo. Int. J. Cancer, 128: 1240–1250. doi: 10.1002/ijc. 25658 DOI: 10.1002/ijc.30271
Author Manuscript
